{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:18:22Z","timestamp":1790090302662,"version":"4.0.1"},"reference-count":37,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00118","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T04:27:45Z","timestamp":1521606465000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption"],"prefix":"10.3389","volume":"9","author":[{"given":"Pierpaolo","family":"Trimboli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Virili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Centanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giovanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/jps.2600671030","article-title":"Dissolution profiles of drugs from tablet","volume":"67","author":"Kitamori","year":"1978","journal-title":"J Pharm Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/thy.1991.1.241","article-title":"Localization of human thyroxine absorption","volume":"1","author":"Hays","year":"1991","journal-title":"Thyroid"},{"key":"B4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3275\/8810","article-title":"How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study","volume":"36","author":"Vaisman","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s40618-017-0706-y","article-title":"Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report","volume":"40","author":"Centanni","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.17925\/EE.2013.09.01.40","article-title":"A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism","volume":"9","author":"Colucci","year":"2013","journal-title":"Eur Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1055\/s-0032-1329951","article-title":"Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms","volume":"62","author":"Yue","year":"2012","journal-title":"Arzneimittelforschung"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2018.00010","article-title":"Levothyroxine therapy: changes of TSH levels by switching patients from tablet to liquid formulation, a systematic review and meta-analysis","volume":"9","author":"Virili","year":"2018","journal-title":"Front Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12020-016-1035-1","article-title":"Liquid and softgel levothyroxine use in clinical practice: state of the art","volume":"54","author":"Virili","year":"2016","journal-title":"Endocrine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12020-012-9772-2","article-title":"A novel formulation of l-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations","volume":"43","author":"Vita","year":"2013","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12020-014-0476-7","article-title":"Thyroxine softgel capsule in patients with gastric-related T4 malabsorption","volume":"49","author":"Santaguida","year":"2015","journal-title":"Endocrine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9043450","DOI":"10.1155\/2016\/9043450","article-title":"Thyroid hormone profile in patients ingesting soft gel capsule or liquid levothyroxine formulations with breakfast","volume":"2016","author":"Cappelli","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.4158\/EP13316.CR","article-title":"Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule","volume":"20","author":"Vita","year":"2014","journal-title":"Endocr Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.4158\/EP14051.CR","article-title":"Levothyroxine malabsorption induced by diabetic gastroparesis exacerbated during pregnancies: effect of intramuscular levothyroxine injections and levothyroxine soft gel capsules","volume":"1","author":"Kim","year":"2015","journal-title":"AACE Clin Case Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fendo.2017.00321","article-title":"l-Thyroxine in an oral liquid or softgel formulation ensures more normal serum levels of free T4 in patients with central hypothyroidism","volume":"20","author":"Benvenga","year":"2017","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s40268-016-0150-z","article-title":"Retrospective study of patients switched from tablet formulations to a gel cap formulation of levothyroxine: results of the CONTROL switch study","volume":"17","author":"Ernst","year":"2017","journal-title":"Drugs R D"},{"key":"B18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12020-017-1311-8","article-title":"Is levothyroxine requirement the same for tablet and soft gel formulations?","volume":"59","author":"Di Donna","year":"2018","journal-title":"Endocrine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.3748\/wjg.v20.i30.10331","article-title":"Helicobacter pylori infection and drugs malabsorption","volume":"20","author":"Lahner","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fendo.2017.00092","article-title":"Hashimoto\u2019s thyroiditis and autoimmune gastritis","volume":"26","author":"Cellini","year":"2017","journal-title":"Front Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"E419","DOI":"10.1210\/jc.2011-1851","article-title":"Atypical celiac disease as cause of increased need for thyroxine: a systematic study","volume":"97","author":"Virili","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E1454","DOI":"10.1210\/jc.2014-1217","article-title":"Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine","volume":"99","author":"Cellini","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0029-1211442","article-title":"Chronic intestinal giardiasis with isolated levothyroxine malabsorption as reason for severe hypothyroidism \u2013 implications for localization of thyroid hormone absorption in the gut","volume":"104","author":"Seppel","year":"1996","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12020-014-0509-2","article-title":"Does microbiota composition affect thyroid homeostasis?","volume":"49","author":"Virili","year":"2015","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mce.2017.01.053","article-title":"\u201cWith a little help from my friends\u201d \u2013 the role of microbiota in thyroid hormone metabolism and enterohepatic recycling","volume":"458","author":"Virili","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1467-789X.2009.00614.x.2","article-title":"A systematic review of drug absorption following bariatric surgery and its theoretical implications","volume":"11","author":"Padwal","year":"2010","journal-title":"Obes Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2265.2007.03091.x","article-title":"Chronic unexplained anaemia in isolated autoimmune thyroid disease or associated with autoimmune related disorders","volume":"68","author":"Sibilla","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12020-015-0836-y","article-title":"Oral l-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study","volume":"52","author":"Fallahi","year":"2016","journal-title":"Endocrine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4158\/EP161545","article-title":"In patients with subclinical hypothyroidism while in therapy with tablet L-T4, the liquid L-T4 formulation is more effective in restoring euthyroidism","volume":"23","author":"Fallahi","year":"2017","journal-title":"Endocr Pract"},{"key":"B30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12020-012-9814-9","article-title":"Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches","volume":"43","author":"Centanni","year":"2013","journal-title":"Endocrine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejpb.2008.10.008","article-title":"A comparative pH-dissolution profile study of selected commercial levothyroxineproducts using inductively coupled plasma mass spectrometry","volume":"72","author":"Pabla","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"B32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.18433\/J36P5M","article-title":"When bioequivalence in healthy volunteers may not translate to bioequivalence in patients: differential effects of increased gastric pH on the pharmacokinetics of levothyroxine capsules and tablets","volume":"18","author":"Seng Yue","year":"2015","journal-title":"J Pharm Pharm Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/thy.1995.5.249","article-title":"Delayed intestinal absorption of levothyroxine","volume":"1995","author":"Benvenga","year":"1995","journal-title":"Thyroid"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa043903","article-title":"Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis","volume":"354","author":"Centanni","year":"2006","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/thy.2017.0380","article-title":"Stable isotope pharmacokinetic studies provide insight into effects of age, sex, and weight on levothyroxine metabolism","volume":"28","author":"Younis","year":"2018","journal-title":"Thyroid"},{"key":"B36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1530\/EJE-15-0314","article-title":"Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study","volume":"173","author":"Del Duca","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1507\/endocrj.EJ16-0040","article-title":"Liquid liothyronine to obtain target TSH in differentiated thyroid cancer patients","volume":"63","author":"Trimboli","year":"2016","journal-title":"Endocr J"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00118\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T04:27:45Z","timestamp":1521606465000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00118\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":37,"alternative-id":["10.3389\/fendo.2018.00118"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00118","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"article-number":"118"}}